Search

everythinglearnresearchcommunity

for

Search:↓

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

MX1 and AR genes are linked to milder COVID-19, while TMPRSS2 increases severe risk, especially in women.

Women, younger age, and low BMI increase the risk of long COVID symptoms.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Age, gender, obesity, and smoking increase the risk of severe COVID-19.

Kampo medicine can help treat general fatigue from long COVID.

There's no significant genetic link between male pattern baldness and COVID-19.

Common dermatology drugs were considered but are controversial for COVID-19 treatment.

Cepharanthine is safe but not effective in significantly reducing COVID-19 recovery time.

Male hormones may increase the severity and death rates of COVID-19.

University students in Egypt experienced high stress during COVID-19's third wave, with negative coping mechanisms being more common.

The pandemic increased stress-related skin conditions and those affected by behavior changes.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Regular mole checks and UV protection are crucial, especially for fair-skinned and health-compromised individuals.

Beau's lines on fingernails might indicate past severe COVID-19 and risk of reinfection.

Most people in South India lack knowledge about managing COVID-19 at home.

Cepharanthine is safe but not clearly effective in speeding up COVID-19 recovery.

The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Contract cheating website traffic in Spain surged during COVID-19 but declined with the rise of AI tools.

More skin issues appeared in the emergency department during COVID-19, highlighting the need for better dermatology training and resources.

Expanding telemedicine in Japan reduced healthcare costs without harming health outcomes.

Resident doctors had more facial skin discoloration than medical students during COVID-19.

Severe hair loss may increase the risk of dying from COVID-19.

Hair loss was the most common skin issue among healthcare workers with COVID-19.

Shirodhara may help improve mental well-being, but more research is needed.

Transcranial electrical stimulation may help reduce certain immune markers in COVID-19 patients.